Home Newsfeeds Raymond James Downgrades CapStar Finl Hldgs to Market Perform

Raymond James Downgrades CapStar Finl Hldgs to Market Perform

Raymond James analyst William Wallace downgrades CapStar Finl Hldgs (NASDAQ:CSTR) from Outperform to Market Perform.

byBenzinga Newsdesk

July 7, 2022

1 minute read

Raymond James analyst William Wallace downgrades CapStar Finl Hldgs (NASDAQ:CSTR) from Outperform to Market Perform.

IBM Q1 Earnings: Revenue Miss, EPS Beat, HashiCorp Acquisition, AI Strategy Strength And More

By Adam Eckert

April 24, 4:23 PM

IBM's first-quarter revenue increased 1% year-over-year to $14.46 billion, which missed the consensus estimate of $14.55 billion, according to Benzinga Pro. The company reported quarterly adjusted earnings of $1.68 per share, which beat analyst estimates of $1.60 per share.

HCP

Acadia Pharmaceuticals Announces Label Update for NUPLAZID; U.S. FDA Revises Boxed Warning To Clarify That Nuplazid Can Be Used To Treat Patients With Parkinson’s Disease-Related Hallucinations And Delusions Who Also Have Dementia

By Benzinga Newsdesk

September 18, 11:20 AM

— U.S. FDA revises Boxed Warning to clarify that NUPLAZID can be used to treat patients with Parkinson's disease-related hallucinations and delusions who also have dementiaSAN DIEGO — September 18, 2023 – Acadia

ACAD

News

micromobility.com Inc. Announces Strategic Realignment To Strengthen Its Financial Position And Drive Profitability

By Happy Mohamed

June 29, 8:13 AM

Exits Streaming Business to Focus on Core Competencies Directing Resources to Mobility to Revolutionize Transportation with Sustainable and Smart Solutions Strengthens Position in Mobility to Navigate towards

MCOM

Meta Says Hate Speech Content Decreased On Facebook And Instagram — Is Elon Musk’s Twitter Listening?

By Ananya Gairola

November 23, 12:36 AM

Meta Platforms Inc. (NASDAQ: META) says the detection of hate speech has decreased significantly on Facebook and Instagram &mdas

Raymond James Downgrades CapStar Finl Hldgs to Market Perform

Related Posts

IBM Q1 Earnings: Revenue Miss, EPS Beat, HashiCorp Acquisition, AI Strategy Strength And More

Acadia Pharmaceuticals Announces Label Update for NUPLAZID; U.S. FDA Revises Boxed Warning To Clarify That Nuplazid Can Be Used To Treat Patients With Parkinson’s Disease-Related Hallucinations And Delusions Who Also Have Dementia

micromobility.com Inc. Announces Strategic Realignment To Strengthen Its Financial Position And Drive Profitability

Meta Says Hate Speech Content Decreased On Facebook And Instagram — Is Elon Musk’s Twitter Listening?